MBD2_v2 overexpression significantly increased tumor initiation capacity of TNBC cells in lean mice, and SRSF2 knockdown, which decreased MBD2_v2 expression, significantly hindered tumor formation capacity in the more tumorigenic context of DIO mice. This evidence concerns the gene SRSF2 and neoplasm.